Skip to main content
. 2022 Jun 30;13:925290. doi: 10.3389/fimmu.2022.925290

Table 1.

Pre-clinical application of nanomaterials for cancer immunotherapy based on ICD.

Material Application (therapy) Experimental conditions Therapeutic agents/adjuvant Tumor model Cell death type Effect Refs
Black phosphorus nanosheets PTT 60 µg/mL + 808 nm, 2W/cm2, 180 s CpG 4T1 Necroptosis CRT activation (67)
HMGB-1 release
ATP secretion
Raw 264.7 ↑ Phagocytosis potential
↑ TNFα
↑ IL-6
2 mg/Kg + 808 nm, 2W/cm2, 1 min Bilateral 4T1 xenografted Balb/c mice Primary and secondary tumor regression
CD8+ T cells activation
CD4+ T cells activation
↓ Treg cells
↑ TNFα
↑ IL-2
↑ IFNɣ
PFP@PEG-CMD-Ce6 Nanobubbles US 100 µg/mL + 300 s, power: 30 W, duty cycle: 20%, pulse repetition frequency: 1Hz, Y interval: 1mm / CT26 RIPK3/MLKL independent necroptosis and
apoptosis
HMGB-1 release (68)
BMDCs ↑ CD86+
On days 8, 11, 14, 1-3 mg Ce6/kg doses + time: 600 sec, power: 10 W, duty cycle: 20%, pulse repetition frequency: 1 Hz, Y interval: 1 mm CT26 xenografted Balb/c mice ↓ Tumor growth
PD-L1
100 µg/mouse
↓↓ Tumor growth
↓ Metastasis
↑ CD8+ T cells infiltration
Poly(lactic-co-glycolic acid) polymeric core-bearing breast cancer membrane biomimetic nanoparticle (BN) NIR-photoactivation 808 nm, 0.5 W/cm2, 2 min Indocyanine green (ICG) 40 µg/mL + decitabine (DCT) 7.6 µg/mL 4T1 Pyroptosis and apoptosis ↑ Ca2+ (58)
↑ Cyt c
↑ caspase 3
↑ GSDME
↑ N-terminal GSDME
(4T1 + BN) + BMDCs ↑ CD86+
↑ TNFα
↑ IL-6
ICG 1 mg/kg + DCT 0.19 mg/kg 4T1 xenografted Balb/c mice ↑ caspase 3
↑ N-terminal GSDME
Bilateral 4T1 xenografted Balb/c mice Primary and secondary tumor regression
↑ TNFα
↑ IL-6
↑ IFNɣ
↑ DCs infiltration
↑ CD8+ T cells infiltration
↑ CD4+ T cells infiltration
↓ Treg cells
Nanoliposome / / DAC pre-treatment (100 µL) + cisplatinum (80 µmol/L-1) 4T1 xenografted Balb/c mice Pyroptosis and apoptosis ↓ Tumor growth (69)
↓ Metastasis
↑ CD8+ T cells infiltration
↑ DCs maturation
Arginine-rich manganese silicate nanobubbles / 1 - 25 µg/mL / Huh7 Ferroptosis ↓ GSH; ↑ GSSG (70)
↓ GPX4
5 mg/kg Huh7 xenografted Balb/c mice ↓ Tumor growth
PEGylated single-atom Fe-containing nanocatalysts / 25 - 400 µg/mL / 4T1 Ferroptosis and apoptosis / (43)
20 mg/kg 4T1 xenografted Balb/c mice ↓ Tumor growth
NIR-photoactivation 20 mg/kg; 808 nm, 1.5 W/cm2, 5 min   Complete tumor regression
Fe-doxorubicin preloaded amorphous CaCo3 nanoformulation / / Doxorubicin 5 mg/kg + Fe2+ 4T1 and A375 nude mice Ferroptosis and apoptosis ↓ Tumor growth
No toxicity
(71)

↑ means "increase"; ↓ means "decrease".